Finasteride Use by Men With BPH Cuts PCa Risk
Links shared publicly online about this topic
Finasteride Use by Men With BPH Cuts PCa Risk - Renal and Urology News
renalandurologynews.com — “Finasteride treatment reduces the risk of low-grade prostate cancer (PCa) in men taking the drug for symptomatic benign prostatic hyperplasia (BPH), data show.” View full resource at renalandurologynews.com
Most Recently Shared on September 17, 2009 at 5:43 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Finasteride Use by Men With BPH Cuts PCa Risk: Finasteride treatment reduces the risk of low-grade prostate canc.. http://bit.ly/iCz8Y
FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention - Renal and Urology News
renalandurologynews.com — “An FDA advisory panel has voted against expanding the labeling of dutasteride (Avodart, GlaxoSmithKline) and finasteride (Proscar, Merck) so that these drugs--"which are indicated for the treatment of benign prostatic hyperplasia (BPH)--"could be marketed for the prevention of prostate cancer (PCa) in men at risk for the disease.” View full resource at renalandurologynews.com
Most Recently Shared on December 3, 2010 at 1:31 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention: An FDA advisory panel has voted against expan... http://bit.ly/dNQ4zo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
Advertisement
